These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
309 related items for PubMed ID: 33030312
21. Planning for Outcomes (P4O) Modeling Tool: Estimating the Impact of Changing the Proportion of Injectable Progestins in the Contraceptive Method Mix. Lebetkin E, Gao X, Taylor D, Maldonado LY, Saad A, Steiner MJ, Dorflinger LJ, Nanda K, Mastro TD. Glob Health Sci Pract; 2019 Jun; 7(2):317-328. PubMed ID: 31189699 [Abstract] [Full Text] [Related]
27. Increased Cervical CD4+CCR5+ T Cells Among Kenyan Sex Working Women Using Depot Medroxyprogesterone Acetate. Lajoie J, Tjernlund A, Omollo K, Edfeldt G, Röhl M, Boily-Larouche G, Cheruiyot J, Kimani M, Kimani J, Oyugi J, Broliden K, Fowke KR. AIDS Res Hum Retroviruses; 2019 Mar; 35(3):236-246. PubMed ID: 30585733 [Abstract] [Full Text] [Related]
30. Incidence of Herpes Simplex Virus Type 2 Infection Among African Women Using Depot Medroxyprogesterone Acetate, a Copper Intrauterine Device, or a Levonorgestrel Implant for Contraception: A Nested Randomized Trial. Mugo NR, Stalter RM, Heffron R, Rees H, Scoville CW, Morrison C, Kourtis AP, Bukusi E, Beksinka M, Philip NM, Beesham I, Deese J, Edward V, Donnell D, Baeten JM, Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium. Clin Infect Dis; 2022 Sep 10; 75(4):586-595. PubMed ID: 34910143 [Abstract] [Full Text] [Related]
31. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa. Myer L, Denny L, Wright TC, Kuhn L. Int J Epidemiol; 2007 Feb 10; 36(1):166-74. PubMed ID: 17175547 [Abstract] [Full Text] [Related]
32. Risk of HIV-1 acquisition among South African women using a variety of contraceptive methods in a prospective study. Palanee-Phillips T, Brown ER, Szydlo D, Matovu Kiweewa F, Pather A, Harkoo I, Nair G, Soto-Torres L, Hillier SL, Baeten JM, MTN-020/ASPIRE Study Team. AIDS; 2019 Aug 01; 33(10):1619-1622. PubMed ID: 31306167 [Abstract] [Full Text] [Related]
34. Hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence. Polis CB, Phillips SJ, Curtis KM, Westreich DJ, Steyn PS, Raymond E, Hannaford P, Turner AN. Contraception; 2014 Oct 01; 90(4):360-90. PubMed ID: 25183264 [Abstract] [Full Text] [Related]
36. Comparison of Female Genital Tract Cytokine and Microbiota Signatures Induced by Initiation of Intramuscular DMPA and NET-EN Hormonal Contraceptives - a Prospective Cohort Analysis. Dabee S, Tanko RF, Brown BP, Bunjun R, Balle C, Feng C, Konstantinus IN, Jaumdally SZ, Onono M, Nair G, Palanee-Phillips T, Gill K, Baeten JM, Bekker LG, Passmore JS, Heffron R, Jaspan HB, Happel AU. Front Immunol; 2021 Oct 01; 12():760504. PubMed ID: 34956191 [Abstract] [Full Text] [Related]
37. Predictors of DMPA-SC continuation among urban Nigerian women: the influence of counseling quality and side effects. Liu J, Shen J, Diamond-Smith N. Contraception; 2018 Nov 01; 98(5):430-437. PubMed ID: 29733817 [Abstract] [Full Text] [Related]